Key clinical point: A genetic and clinical risk factor score may offer a better way to predict venous thromboembolism risk in patients with lymphoma.
Major finding: The TiC-Lympho score for venous thromboembolism risk among lymphoma patients had a sensitivity of 93.55% and a specificity of 54.49%.
Study details: A retrospective study in 208 patients with lymphoma.
Disclosures: No conflicts of interest were reported.
Pascual C et al. 2019 ISTH Congress, Abstract OC 41.3.